Enzyme Replacement Therapy to Treat Advanced Heart Failure. Learn more...
Wednesday, Dec 11th, 2013Celladon Corporation Announces Receipt of EMA Scientific Advice for MYDICAR® and Initiation of AGENT-HF Trial
Monday, Nov 18th, 2013Celladon Corporation Announces Oral Presentation at American Heart Association of Long Term Follow-Up Results from the MYDICAR CUPID 1 Trial in Advanced Heart Failure
Heartening Results: The CUPID Gene Therapy Trial for Heart Failure
HOME | ABOUT US | RESEARCH & DEVELOPMENT | INVESTORS | NEWS & EVENTS | CONTACT | SEARCH
Celladon Corporation © 2005-